Type 2 Diabetes

Type 2 diabetes, formerly called adult-onset or noninsulindependent diabetes, is the most common form of diabetes. People can develop type 2 diabetes at any age, even during childhood. This form of diabetes usually begins with insulin resistance, a condition in which fat, muscle, and liver cells do not use insulin properly. At first, the pancreas keeps up with the added demand by producing more insulin. In time, however, it loses the ability to secrete enough insulin in response to meals. People who are overweight and inactive are more likely to develop type 2 diabetes. Treatment includes taking diabetes medicines, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.

What is Type 2 Diabetes?

Type 2 diabetes is a common metabolic condition that develops when the body fails to produce enough insulin or when insulin fails to work properly, which is referred to as insulin resistance. Insulin is the hormone that stimulates cells to uptake glucose from the blood to use for energy.

Diabetes in Men versus Women

Type 2 Diabetes Symptoms

Insulin Resistance Diagnosis

Does the Keto Diet Increase the Risk of Diabetes?

Insulin Resistance and Parkinson's Disease

Vitamin D and Type 2 Diabetes

Insulin Resistance Treatment

What is Diabetes?

Type 2 Diabetes Screening and Prevention

Insulin Resistance Pathophysiology

Type 2 Diabetes Treatment

See more featured articles »

Living With Type 2 Diabetes

Causes of Insulin Resistance

What is Insulin Resistance?

Is a Plant-Based Diet Good for Type 2 Diabetes?

Insulin Medication

Diabetes Mellitus Type 2 Pathophysiology

Type 2 Diabetes Diagnosis

The Risks of Prediabetes

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

Insulin Resistance Symptoms

Fibromyalgia and Diabetes

Latest Type 2 Diabetes News and Research

Experimental compound reduces cell death, inflammation, and organ damage in diabetes

An experimental compound reduced the cell death, inflammation, and organ damage seen with diabetes.

29 Oct 2025

Four distinct subgroups of PCOS open up for more tailored treatments

Four distinct subgroups of polycystic ovary syndrome (PCOS) have been identified in an international study published in Nature Medicine by researchers from Karolinska Institutet, among others.

29 Oct 2025

Heatwaves can significantly worsen obstructive sleep apnea

During heatwaves, there is an increase in the number of people suffering with obstructive sleep apnoea (OSA), according to a major study published today (Wednesday) in the European Respiratory Journal.

29 Oct 2025

Plant-based diets could curb climate change and infectious diseases, experts say

A new review in Open Forum Infectious Diseases links animal agriculture to climate change, antimicrobial resistance, and infectious disease spread. The authors urge healthcare providers to promote plant-based diets as a practical step to protect planetary and public health.

28 Oct 2025

AI-powered LifeClock forecasts diseases years before symptoms appear

Researchers have developed LifeClock, an AI-driven biological clock trained on over 24 million electronic health records to estimate biological age across the human lifespan. The model accurately predicts disease risk years in advance, revealing distinct developmental and aging processes.

28 Oct 2025

Circadian rhythm disruptions may increase the risk of cardiovascular disease

As modern lifestyles increasingly challenge the body's natural circadian rhythm, the American Heart Association is spotlighting the potential health consequences of regular disruptions to our body's internal clock with a new scientific statement published today in its flagship journal Circulation.

28 Oct 2025

Obesity’s health risks shift with age and sex, new genetic study reveals

Using a new time-resolved Mendelian randomization approach in over 360,000 UK Biobank participants, Karlsson et al. revealed that the causal impact of obesity changes across life, with distinct age- and sex-specific risk patterns for diabetes, heart disease, atrial fibrillation, and osteoarthritis.

27 Oct 2025

AI-powered app matches human-led programs in diabetes prevention

Researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report that an AI-powered lifestyle intervention app for prediabetes reduced the risk of diabetes similarly to traditional, human-led programs in adults.

27 Oct 2025

Study finds bright nights raise risk for stroke and heart failure in adults over 40

A large UK Biobank study found that higher night-time light exposure is linked to significantly greater risks of coronary artery disease, stroke, heart failure, and other cardiovascular conditions. The findings suggest maintaining darker nights and adequate daytime light could support heart health.

26 Oct 2025

Semaglutide protects the heart beyond weight loss, SELECT trial shows

Semaglutide lowered the risk of major adverse cardiovascular events across all body weight and waist circumference levels in people with overweight or obesity and cardiovascular disease. Early waist reduction explained only a third of this benefit, showing that semaglutide’s heart protection extends beyond fat loss.

26 Oct 2025

Are ultra-processed plant foods really worse than meat? Scientists weigh in

A new review challenges assumptions about ultra-processed foods, finding that plant-based versions, such as soymilk, meat analogs, and soft margarines, may lower cholesterol and disease risk compared with unprocessed animal foods when used as replacements.

26 Oct 2025

Food tax shift could have both environmental and human health benefits

More expensive steak, cheaper tomatoes, but the same total cost for the average basket of groceries at the supermarket.

24 Oct 2025

Dietary fat dictates seasonal eating rhythms, study finds

A new study from UC San Francisco shows that our natural eating patterns are more closely tied to seasonal rhythms than previously thought.

23 Oct 2025

New York Regional Diabetes Research Center established with $10.8 million NIH grant

Albert Einstein College of Medicine has received a five-year, $10.8 million grant from the National Institutes of Health (NIH) to create the New York Regional Diabetes Research Center (NYR-DRC), a newly expanded multi-institutional center co-led with the Icahn School of Medicine at Mount Sinai and Weill Cornell Medicine.

23 Oct 2025

Intensive program leads to high type 2 diabetes remission in India

Nearly one-third of people with type 2 diabetes (T2D) in an Indian cohort achieved remission through an intensive lifestyle intervention program, according to a new study publishing October 22, 2025, in the open-access journal PLOS One by Pramod Tripathi of Freedom from Diabetes Clinic & Diabetes Research Foundation, India, and colleagues.

23 Oct 2025

E2F2 protein identified as potential therapeutic target to prevent metabolic fatty liver disease progression

An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, such as cirrhosis or liver cancer.

22 Oct 2025

Scientists question the safety and efficacy of the diet for metabolic health

A study published in Science Advances by University of Utah Health researchers sheds light on the long-term effects of the ketogenic diet, raising important questions about its safety and efficacy for improving metabolic health.

22 Oct 2025

Can strawberries help prevent diabetes? New trial shows promising results in prediabetic adults

Daily consumption of freeze-dried strawberries for 12 weeks improved antioxidant defense, reduced inflammation, and lowered fasting glucose in adults with prediabetes. The randomized crossover trial highlights strawberries’ potential as a simple, food-based strategy to enhance metabolic and vascular health.

21 Oct 2025

Early menopause increases risk of metabolic syndrome in women

The prevalence of metabolic syndrome, a dangerous and potentially deadly condition, increases with menopause.

21 Oct 2025

Neighborhood environments can influence a child's risk of developing type 2 diabetes

Type 2 diabetes (T2D), once considered an adult-onset disease, is increasing at alarming rates in children and adolescents. Before the mid-1990s, just 1% to 2% of youth with diabetes had T2D.

21 Oct 2025